Indications, practice, and procedural outcomes of percutaneous transluminal coronary angioplasty in Northern New England in the early 1990s

American Journal of Cardiology

Volumn 78, Issue 3, 1996, Pages 260-265

  Malenka, David J ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; UNSTABLE ANGINA PECTORIS;

EID: 0030221066     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00274-3     Document Type: Article

References (19)

1. Feinleib M, Havlik RJ, Gillum F, Pokras R, McCarthy E, Moien M Coronary heart disease and related procedures: national hospital discharge survey data. Circulation. 79((suppl I)):1989;I-13-I-18.
2. Detre K, Holubnkov R, Kelsey S, Cowley M, Kent K, Williams D, Myler R, Faxon D, Holmes D Jr., Bourassa M, Block P, Gosselin A, Bentivoglio L, Leatherman L, Dorros G, King S III, Galichia J, Al-Bassam M, Leon M, Robertson T, Passamani E Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981: The National Heart, Lung, and Blood Institute Registry. N Engl J Med. 318:1988;265-270.
3. Hannan EL, Arani DT, Johnson LW, Kemp HG Jr., Lukacik G Percutaneous transluminal coronary angioplasty in New York state: risk factors and outcomes. JAMA. 268:1992;3092-3097.
4. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O'Neill WW, and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-588.
5. Simoons ML, Arnold AER, Betriu A, de Bono DP, Col J, Dougherty FC, von Essen R, Lambertz H, Lubsen J, Meier B, Michel PL, Raymond P, Rutsch W, Sanz GA, Schmidt D, Verstraete M Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1:1988;197-203.
6. The TIMI Study Group Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 320:1989;618-627.
7. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vilietstra RE, Strzelecki M, Puchrowicz-Ochocki S, O'Neill W A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
8. TIMI IIIB Investigators Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave infarction: results of the TIMI IIIB trial. Circulation. 89:1994;1545-1556.
9. RITA Trial Participants Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet. 341:1993;573-580.
10. Rodriguez A, Boullon F, Perez-Balino N, Paviotti E, Liprandi MI, Palaciosi F Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. J Am Coll Cardiol. 22:1993;1060-1067.
11. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W A randomized study of coronary angioplasty versus bypass-surgery in patients with symptomatic multivessel coronary disease. N Engl J Med. 331:1994;1037-1043.
12. King SB III, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MN, Alazraki NP, Guyton RA, Zhao XQ A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med. 331:1994;1044-1050.
13. Protocol for the Bypass Angioplasty Revascularization Investigation Circulation. 84((suppl V)):1991;V-1-V-27.
14. O'Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT, Nowicki ER, Tryzelaar JF, Hernandez F, Adrian L, Casey KJ, Soule DN, Marrin CAS, Nugent WC, Charlesworth DC, Clough R, Katz S, Leavitt BJ, Wennberg JE A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. JAMA. 266:1991;803-809.
15. O'Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT, Nowicki ER, Levy DG, Tryzelaar JF, Hernandez F, Adrian L, Casey KJ, Bundy D, Soule DN, Marrin CAS, Nugent WC, Charlesworth DC, Clough R, Katz S, Leavitt BJ, Wennberg JE Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Circulation. 85:1992;2110-2118.
16. O'Connor GT, Morton JR, Diehl MJ, Olmstead EM, Coffin LH, Levy DG, Maloney CT, Plume SK, Nugent W, Malenka DJ Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation. 88:1993;2104-2110.
17. Kilip T, ed. The National Heart, Lung, and Blood Institute Coronary Artery Surgery Study (CASS). Circulation 1981;63 (suppl I):I-1-I-81.
18. ACC/AHA Task Force Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 12:1988;529-545.
19. Ritchie JL, Phillips KA, Luft HS Coronary angioplasty. Statewide experience in California. Circulation. 88:1993;2735-2743.